Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee; Notice of Meeting, 19189 [2011-8115]

Download as PDF 19189 Federal Register / Vol. 76, No. 66 / Wednesday, April 6, 2011 / Notices Panel Date(s) Immunology .............................................................................................. Infectious Diseases-A ............................................................................... Cardiovascular Studies ............................................................................. Neurobiology-D ......................................................................................... Clinical Research Program ....................................................................... Gastroenterology ...................................................................................... June June June June June June Location 9, 2011 .................................. 9, 2011 .................................. 10, 2011 ................................ 10, 2011 ................................ 13, 2011 ................................ 13, 2011 ................................ L’Enfant Plaza Hotel. L’Enfant Plaza Hotel. Crowne Plaza DC/Silver Spring. Crowne Plaza DC/Silver Spring. VA Central Office.* L’Enfant Plaza Hotel. The addresses of the hotels and VA Central Office are: Plaza Washington DC/Silver Spring, 8777 Georgia Avenue, Silver Spring, MD. Hamilton Crowne Plaza, 1001–14th Street, NW., Washington, DC. L’Enfant Plaza Hotel, 480 L’Enfant Plaza, SW., Washington, DC. * VA Central Office, 131 M Street, NE., Washington, DC. * Teleconference. mstockstill on DSKH9S0YB1PROD with NOTICES The purpose of the Merit Review Board is to provide advice on the scientific quality, budget, safety and mission relevance of investigatorinitiated research proposals submitted for VA merit review consideration. Proposals submitted for review by the Board involve a wide range of medical specialties within the general areas of biomedical, behavioral and clinical science research. The panel meetings will be open to the public for approximately one hour at the start of each meeting to discuss the general status of the program. The remaining portion of each panel meeting will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals. The closed portion of each meeting involves discussion, examination, reference to staff and consultant critiques of research proposals. During this portion of each meeting, discussion and recommendations will deal with qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy, as well as research information, the premature disclosure of which could significantly frustrate implementation of proposed agency action regarding such research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended, closing portions of these panel meetings is in accordance with 5 U.S.C., 552b(c)(6) and (9)(B). Those who plan to attend or would like to obtain a copy of minutes of the panel meetings and rosters of the members of the panels should contact VerDate Mar<15>2010 16:52 Apr 05, 2011 Jkt 223001 LeRoy G. Frey, PhD, Chief, Program Review (121F), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420 at (202) 443– 5674. Dated: March 31, 2011. By Direction of the Secretary. William F. Russo, Director of Regulations Management, Office of General Counsel. [FR Doc. 2011–8114 Filed 4–5–11; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee will be held on April 25, 2011, at The Ritz-Carlton Hotel, 1150 22nd Street, NW., Washington, DC. The meeting is scheduled to begin at 9 a.m. and end at 3 p.m. The Committee advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical PO 00000 Frm 00161 Fmt 4703 Sfmt 9990 details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the meeting will be closed to the public for the Committee’s review, discussion and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (125), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, or e-mail at grant.huang@va.gov or phone at (202) 443–5600. Dated: March 31, 2011. By Direction of the Secretary. William F. Russo, Director of Regulations Management, Office of General Counsel. [FR Doc. 2011–8115 Filed 4–5–11; 8:45 am] BILLING CODE P E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 76, Number 66 (Wednesday, April 6, 2011)]
[Notices]
[Page 19189]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8115]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Clinical Science Research and Development Service Cooperative 
Studies Scientific Evaluation Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Clinical Science Research and Development Service Cooperative Studies 
Scientific Evaluation Committee will be held on April 25, 2011, at The 
Ritz-Carlton Hotel, 1150 22nd Street, NW., Washington, DC. The meeting 
is scheduled to begin at 9 a.m. and end at 3 p.m.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Clinical Science Research and Development 
Service on the relevance and feasibility of proposed projects and the 
scientific validity and propriety of technical details, including 
protection of human subjects.
    The session will be open to the public for approximately 30 minutes 
at the start of the meeting for the discussion of administrative 
matters and the general status of the program. The remaining portion of 
the meeting will be closed to the public for the Committee's review, 
discussion and evaluation of research and development applications.
    During the closed portion of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals and 
similar documents and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. As provided by section 10(d) 
of Public Law 92-463, as amended, closing portions of this meeting is 
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
    Those who plan to attend should contact Dr. Grant Huang, Deputy 
Director, Cooperative Studies Program (125), Department of Veterans 
Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, or e-mail at 
grant.huang@va.gov or phone at (202) 443-5600.

    Dated: March 31, 2011.

    By Direction of the Secretary.
William F. Russo,
Director of Regulations Management, Office of General Counsel.
[FR Doc. 2011-8115 Filed 4-5-11; 8:45 am]
BILLING CODE P